AttoQuest is a UNSW spin-off company established to take discoveries from state-of-the-art research facilities to the field, to impact and improve health globally. The have developed a fast, simple and sensitive technology for early and rapid diagnostic testing of infectious diseases.
This technology has the potential to increase our current sensitivity and specificity, which increase accuracy and speed of diagnosis.
AttoQuest was part of Health10x and is now part of cohort #4 of UNSW Founder's Flagship accelerator Founders 10x, which assists in supporting UNSW Alumni, Startup Communities and Entrepreneurship.
